bioAffinity Technologies CEO Maria Zannes to present at H.C. Wainwright conference
bioAffinity Technologies, Inc. said President and CEO Maria Zannes will present a corporate update and hold one-on-one investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.